chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sinusitis
Clinical narrative: I was very tired and then started coughing really badly on Saturday. I had a sinus infection, but it was gone at that point and then my daughter insisted I test for COVID-19 when I started coughing. I had a slight fever and was coughing and was so tired. I ended up being bedridden for over a month. My doctor did give me a medication and cough syrup to help with the symptoms I was having. I did have my flu vaccine on the same date as my COVID-19 shot but I do not have the information for that shot.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: On 12/02/2022 did a PCR Covid-19 test and it was positive. I had a sore throat and cough. I did take PAXLOVID for 5 days from 12/02/22-12/07/2022.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Axillary pain, Bone contusion, Muscle swelling, Musculoskeletal chest pain, Myalgia
Clinical narrative: Moderate swelling and pain in right armpit, side of ribs, and tricep 1 day after vaccination, swelling/pain has not subsided after  72 hrs . Slight bruising on side of ribs 72 hrs after vaccination. Pain/slight swelling right side of neck 1 day after vaccination. Fever and nausea 12 hrs after vaccination but subsided 24 hrs after.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nausea, Neck pain, Oedema peripheral, Pyrexia, Swelling
Clinical narrative: Moderate swelling and pain in right armpit, side of ribs, and tricep 1 day after vaccination, swelling/pain has not subsided after  72 hrs . Slight bruising on side of ribs 72 hrs after vaccination. Pain/slight swelling right side of neck 1 day after vaccination. Fever and nausea 12 hrs after vaccination but subsided 24 hrs after.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syringe issue, Underdose
Clinical narrative: Upon give the injection, the syringe failed and part of the dose leaked out of the side of the syringe. The patient did not received a full dose.  The patient will try at a later date to get a full dose at a different pharmacy.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Fatigue, Feeling abnormal, Impaired work ability
Clinical narrative: On December 5, 2022, I woke up not feeling good. I began to feel weak and tired. I began to feel worse before the night. Within two days I was congested. I tested positive for COVID-19 at home on December 6, 2022. I started to run a fever. I was prescribed PAXLOVID and began to take it Tuesday and was back to work on Thursday.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: On December 5, 2022, I woke up not feeling good. I began to feel weak and tired. I began to feel worse before the night. Within two days I was congested. I tested positive for COVID-19 at home on December 6, 2022. I started to run a fever. I was prescribed PAXLOVID and began to take it Tuesday and was back to work on Thursday.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Nasopharyngitis, SARS-CoV-2 test negative
Clinical narrative: I received the second dose of the Pfizer COVID-19 vaccine on 3/11/2021. In August 2021, my husband tested positive for COVID-19. I avoided contact with him as much as possible. I was also tested for COVID-19, and the result was negative. I thought I was COVID-19-free until I was working in the garden one day and noticed I couldn't smell the basil or tomatoes. My doctor advised me that even if I had tested negative for COVID-19, if I had any symptoms of it, I had most likely caught it. I never developed any symptoms of COVID-19 besides the loss of the sense of smell, though I did have mild cold-like symptoms. I don't remember how long I was unable to smell, but I did eventually regain my sense of smell.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 01/08/2022. On 12/13/2022 I started to experience coughing sneezing chills and a fever. On 12/14/2022 I tested COVID-19 positive with an at home test. I sent a note to my primary doctor and told to rest fluids isolate. I still have a lingering COVID-19 presently on 01/09/2023.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: I had my vaccination on 01/08/2022. On 12/13/2022 I started to experience coughing sneezing chills and a fever. On 12/14/2022 I tested COVID-19 positive with an at home test. I sent a note to my primary doctor and told to rest fluids isolate. I still have a lingering COVID-19 presently on 01/09/2023.
Age: 44.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rash
Clinical narrative: Pt stated he developed a rash  that started at the neck then gradually spread to all over the body - rash started on sunday 1/8/23 first pfizer dose, had previously been getting moderna
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: I was confused by the survey questions asked.   After the October vaccination, I came down with Covid-19 in December.   There were no adverse effects to the injection.   My doctor proscribed  a five day course of Paxlovid.   I had no adverse  effects to the Paxlovid.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Unevaluable event
Clinical narrative: none
Age: 1.58
Sex: M
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Hepatitis A vaccination was administered two months prior to due date for series. Patient was unharmed otherwise.
Age: 70.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Influenza like illness, Nasopharyngitis
Clinical narrative: COLD AND FLU-LIKE SYMPTOMS  RECOVERED FULLY WITHIN A WEEK OR SO
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac flutter, Fatigue, Palpitations
Clinical narrative: I have had A-Fib and I seem more tired than I was before the vaccination. My heart started racing and fluttering. I went to the hospital and they said I had A-Fib. I was prescribed several medications.
Age: 1.08
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: was given trumemba instead of prevnar 13.
Age: 3.0
Sex: F
Vaccine: DTAP
Symptoms: Rash erythematous, Skin warm
Clinical narrative: Red rash that was warm to touch
Age: 4.0
Sex: F
Vaccine: DTAP, MMRV
Symptoms: Rash, Urticaria
Clinical narrative: Breakout(hives)
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt received the Original Pzf Primary Series instead of the updated Bivalent. Pt was informed and will return to pharmacy in 2 months for the bivalent booster
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Diarrhoea, Pyrexia, Rash, Vomiting
Clinical narrative: fever , vomitting, diarreah , rash to leg
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: I had cold chilis, low grade fever.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 10/07/2022. I started to experience fatigue on 01/02/2023. I tested COVID-19 positive on 01/03/2023. I was not put on any medication because of excellent health. I had biked 37 miles on 01/02/2023. The nurse practitioner sent in the prescription but I didn't take as I was feeling better by day 3.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Atypical pneumonia, Cough, Oropharyngeal pain, SARS-CoV-2 test negative, Throat tightness
Clinical narrative: November 22, 2022, I had a mild sore throat and tight almost like an allergic reaction but not quite. The following days I started to get a chesty cough and began to have a slight wheezing. November 28th, I went to urgent care. I had a COVID-19 test and it was negative. I was diagnosed with walking pneumonia. I was prescribed Z-PAK. I was told to take hot showers and hydrate. By Friday most symptoms have subsided, but I continue to have the deep, chesty, cough but not as often.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: November 22, 2022, I had a mild sore throat and tight almost like an allergic reaction but not quite. The following days I started to get a chesty cough and began to have a slight wheezing. November 28th, I went to urgent care. I had a COVID-19 test and it was negative. I was diagnosed with walking pneumonia. I was prescribed Z-PAK. I was told to take hot showers and hydrate. By Friday most symptoms have subsided, but I continue to have the deep, chesty, cough but not as often.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vaccination site discolouration
Clinical narrative: I have hypopigmentation in the shape of the bandage applied after vaccination. It has been more than 1 year. I have since used bandages without hypopigmentation.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Brain neoplasm, Muscular weakness, Spinal disorder
Clinical narrative: Weakness in lower leg and arms; spinal issues,-grapefruit size tumor that moved up to base of brain
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Headache, Middle insomnia, Oropharyngeal pain, Pain
Clinical narrative: Positive Covid test after vaccination. Woke up congested and sore throat in middle of the night. Headache and body ache continues with congestion.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Positive Covid test after vaccination. Woke up congested and sore throat in middle of the night. Headache and body ache continues with congestion.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ear infection, Nasopharyngitis, Streptococcus test negative
Clinical narrative: No issues at time of vaccine. had a cold and ear infection
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Antipsychotic drug level increased, Asthenia, Balance disorder, Blood creatinine increased
Clinical narrative: The patient is a 64 y.o. male with history of HTN, HLD, diabetes, schizoaffective disorder, GERD, presented to the Medical Center with generalized weakness found to be COVID positive.    Covid-19 Virus Infection Symptoms present on admission: Fever, weakness.  Date of covid positive test: 12/16/22 Vaccination status: vaccinated Imaging: CXR no acute process. Oxygen requirements on admission:  RA Medical therapy: ID consulted, held off on paxlovid but has strong interaction w/ clozaril and could affect levels; I feel risk outweighs benefit Consultants following:  Anticipated special isolation end date: 12/26   Generalized weakness Frequent falls  Secondary to COVID, possible dehydration, elevated lithium level   Brother reported he was very unsteady and falling at home PT/OT consulted, rec 2-3 days per week Family apprehensive about patient returning home without supervision given that he lives alone, but planning to make some arrangements so that he will have someone with him around the clock at least in the short term     Acute kidney injury, resolved  Baseline Cr 1.1-1.2 Up to 2.3 12/18 despite 1L IVF the day prior, likely dehydration pre-renal UA on admission unrevealing US w/o obstruction  Will DC fluids; encourage PO intake  Normalized day of DC Hold losartan at DC until seen by PCP in follow up  Lithium held, ok to resume at reduced dose at DC  Acute metabolic encephalopathy, fluctuating Unclear baseline mentation, however per brother generally independent w/ some assistance from home nurse Likely due to COVID/dehydration, elevated lithium level  CTH no acute process Reported urinary frequency (this is chronic, may have some DI from chronic lithium use) but UA negative Aox3, no focal deficit Delirium prevention measures, maintain sleep wake cycle  Remains impulsive and forgetful but seems to be close to BL day of DC   Schizoaffective disorder, bipolar type Recently seen by BH day prior to admission Resumed home medications Clozapine, Lithium, ativan.  Lithium level elevated at 1.4-- > 2.9; now improved . Likely related to dehydration.  BH consulted. Resumed clozaril at 400mg nightly (decreased from 450mg nightly)  Lithium held w/ AKI; discussed with doctor - recommend resuming at reduced dose 300mg BID Previously on Invega, last dose in 11/2022. Follow up w/ outpatient prescriber whether this should be continued    Essential hypertension Resume home meds Norvasc, metoprolol.  Losartan held w/ AKI and at DC given BP stable   Diabetes Mellitus Holding home canagliflozin at DC due to dehydration, recent AKI BG well controlled here A1c 5.9%   Abnormal US US renal/bladder 12/19: indeterminate polylocular cyst vs multifocal adjacent simple cysts R kidney Recommend MRI abd vs US at 4-6 mo to ensure stability
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram head normal, Dehydration, Fall
Clinical narrative: The patient is a 64 y.o. male with history of HTN, HLD, diabetes, schizoaffective disorder, GERD, presented to the Medical Center with generalized weakness found to be COVID positive.    Covid-19 Virus Infection Symptoms present on admission: Fever, weakness.  Date of covid positive test: 12/16/22 Vaccination status: vaccinated Imaging: CXR no acute process. Oxygen requirements on admission:  RA Medical therapy: ID consulted, held off on paxlovid but has strong interaction w/ clozaril and could affect levels; I feel risk outweighs benefit Consultants following:  Anticipated special isolation end date: 12/26   Generalized weakness Frequent falls  Secondary to COVID, possible dehydration, elevated lithium level   Brother reported he was very unsteady and falling at home PT/OT consulted, rec 2-3 days per week Family apprehensive about patient returning home without supervision given that he lives alone, but planning to make some arrangements so that he will have someone with him around the clock at least in the short term     Acute kidney injury, resolved  Baseline Cr 1.1-1.2 Up to 2.3 12/18 despite 1L IVF the day prior, likely dehydration pre-renal UA on admission unrevealing US w/o obstruction  Will DC fluids; encourage PO intake  Normalized day of DC Hold losartan at DC until seen by PCP in follow up  Lithium held, ok to resume at reduced dose at DC  Acute metabolic encephalopathy, fluctuating Unclear baseline mentation, however per brother generally independent w/ some assistance from home nurse Likely due to COVID/dehydration, elevated lithium level  CTH no acute process Reported urinary frequency (this is chronic, may have some DI from chronic lithium use) but UA negative Aox3, no focal deficit Delirium prevention measures, maintain sleep wake cycle  Remains impulsive and forgetful but seems to be close to BL day of DC   Schizoaffective disorder, bipolar type Recently seen by BH day prior to admission Resumed home medications Clozapine, Lithium, ativan.  Lithium level elevated at 1.4-- > 2.9; now improved . Likely related to dehydration.  BH consulted. Resumed clozaril at 400mg nightly (decreased from 450mg nightly)  Lithium held w/ AKI; discussed with doctor - recommend resuming at reduced dose 300mg BID Previously on Invega, last dose in 11/2022. Follow up w/ outpatient prescriber whether this should be continued    Essential hypertension Resume home meds Norvasc, metoprolol.  Losartan held w/ AKI and at DC given BP stable   Diabetes Mellitus Holding home canagliflozin at DC due to dehydration, recent AKI BG well controlled here A1c 5.9%   Abnormal US US renal/bladder 12/19: indeterminate polylocular cyst vs multifocal adjacent simple cysts R kidney Recommend MRI abd vs US at 4-6 mo to ensure stability
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin normal, Impulsive behaviour, Memory impairment, Metabolic encephalopathy, Pollakiuria
Clinical narrative: The patient is a 64 y.o. male with history of HTN, HLD, diabetes, schizoaffective disorder, GERD, presented to the Medical Center with generalized weakness found to be COVID positive.    Covid-19 Virus Infection Symptoms present on admission: Fever, weakness.  Date of covid positive test: 12/16/22 Vaccination status: vaccinated Imaging: CXR no acute process. Oxygen requirements on admission:  RA Medical therapy: ID consulted, held off on paxlovid but has strong interaction w/ clozaril and could affect levels; I feel risk outweighs benefit Consultants following:  Anticipated special isolation end date: 12/26   Generalized weakness Frequent falls  Secondary to COVID, possible dehydration, elevated lithium level   Brother reported he was very unsteady and falling at home PT/OT consulted, rec 2-3 days per week Family apprehensive about patient returning home without supervision given that he lives alone, but planning to make some arrangements so that he will have someone with him around the clock at least in the short term     Acute kidney injury, resolved  Baseline Cr 1.1-1.2 Up to 2.3 12/18 despite 1L IVF the day prior, likely dehydration pre-renal UA on admission unrevealing US w/o obstruction  Will DC fluids; encourage PO intake  Normalized day of DC Hold losartan at DC until seen by PCP in follow up  Lithium held, ok to resume at reduced dose at DC  Acute metabolic encephalopathy, fluctuating Unclear baseline mentation, however per brother generally independent w/ some assistance from home nurse Likely due to COVID/dehydration, elevated lithium level  CTH no acute process Reported urinary frequency (this is chronic, may have some DI from chronic lithium use) but UA negative Aox3, no focal deficit Delirium prevention measures, maintain sleep wake cycle  Remains impulsive and forgetful but seems to be close to BL day of DC   Schizoaffective disorder, bipolar type Recently seen by BH day prior to admission Resumed home medications Clozapine, Lithium, ativan.  Lithium level elevated at 1.4-- > 2.9; now improved . Likely related to dehydration.  BH consulted. Resumed clozaril at 400mg nightly (decreased from 450mg nightly)  Lithium held w/ AKI; discussed with doctor - recommend resuming at reduced dose 300mg BID Previously on Invega, last dose in 11/2022. Follow up w/ outpatient prescriber whether this should be continued    Essential hypertension Resume home meds Norvasc, metoprolol.  Losartan held w/ AKI and at DC given BP stable   Diabetes Mellitus Holding home canagliflozin at DC due to dehydration, recent AKI BG well controlled here A1c 5.9%   Abnormal US US renal/bladder 12/19: indeterminate polylocular cyst vs multifocal adjacent simple cysts R kidney Recommend MRI abd vs US at 4-6 mo to ensure stability
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Renal cyst, SARS-CoV-2 test positive, Ultrasound kidney abnormal, Urine analysis normal
Clinical narrative: The patient is a 64 y.o. male with history of HTN, HLD, diabetes, schizoaffective disorder, GERD, presented to the Medical Center with generalized weakness found to be COVID positive.    Covid-19 Virus Infection Symptoms present on admission: Fever, weakness.  Date of covid positive test: 12/16/22 Vaccination status: vaccinated Imaging: CXR no acute process. Oxygen requirements on admission:  RA Medical therapy: ID consulted, held off on paxlovid but has strong interaction w/ clozaril and could affect levels; I feel risk outweighs benefit Consultants following:  Anticipated special isolation end date: 12/26   Generalized weakness Frequent falls  Secondary to COVID, possible dehydration, elevated lithium level   Brother reported he was very unsteady and falling at home PT/OT consulted, rec 2-3 days per week Family apprehensive about patient returning home without supervision given that he lives alone, but planning to make some arrangements so that he will have someone with him around the clock at least in the short term     Acute kidney injury, resolved  Baseline Cr 1.1-1.2 Up to 2.3 12/18 despite 1L IVF the day prior, likely dehydration pre-renal UA on admission unrevealing US w/o obstruction  Will DC fluids; encourage PO intake  Normalized day of DC Hold losartan at DC until seen by PCP in follow up  Lithium held, ok to resume at reduced dose at DC  Acute metabolic encephalopathy, fluctuating Unclear baseline mentation, however per brother generally independent w/ some assistance from home nurse Likely due to COVID/dehydration, elevated lithium level  CTH no acute process Reported urinary frequency (this is chronic, may have some DI from chronic lithium use) but UA negative Aox3, no focal deficit Delirium prevention measures, maintain sleep wake cycle  Remains impulsive and forgetful but seems to be close to BL day of DC   Schizoaffective disorder, bipolar type Recently seen by BH day prior to admission Resumed home medications Clozapine, Lithium, ativan.  Lithium level elevated at 1.4-- > 2.9; now improved . Likely related to dehydration.  BH consulted. Resumed clozaril at 400mg nightly (decreased from 450mg nightly)  Lithium held w/ AKI; discussed with doctor - recommend resuming at reduced dose 300mg BID Previously on Invega, last dose in 11/2022. Follow up w/ outpatient prescriber whether this should be continued    Essential hypertension Resume home meds Norvasc, metoprolol.  Losartan held w/ AKI and at DC given BP stable   Diabetes Mellitus Holding home canagliflozin at DC due to dehydration, recent AKI BG well controlled here A1c 5.9%   Abnormal US US renal/bladder 12/19: indeterminate polylocular cyst vs multifocal adjacent simple cysts R kidney Recommend MRI abd vs US at 4-6 mo to ensure stability
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Feeding disorder, Loss of personal independence in daily activities, Mobility decreased, Vertigo, Vomiting
Clinical narrative: EXTREME vertigo upon waking up in the morning, so bad I couldn't move or eat, vomiting when I tried to get up to the bathroom, no fever or other symptoms. Could not go about my daily activities (eg relative had to drive the car for me to return home). With meclizine I was able to manage someone driving me in the car and airplane ride home. No vision change, hearing loss or numbness or weakness.  Lasted 3 days, though progressively better each day and periodically for months after when going from sitting to lying down.
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Anticoagulant therapy, Atelectasis, Blood pressure abnormal, Blood thyroid stimulating hormone normal
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chest X-ray abnormal, Chest pain, Computerised tomogram head normal, Computerised tomogram spine
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyspnoea, Electrocardiogram normal, Fall, Gastric ulcer, Haematochezia
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haematocrit, Haemoglobin decreased, Hypotension, Hypothyroidism, Hypoxia
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lung opacity, Malaise, Melaena, Oesophagogastroduodenoscopy abnormal, Pneumonia
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Presyncope, Rectal haemorrhage, Respiratory tract congestion, SARS-CoV-2 test positive, Spinal osteoarthritis
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Staphylococcus test negative, Syncope, Thrombosis, Troponin normal, Upper gastrointestinal haemorrhage
Clinical narrative: Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Gastrointestinal haemorrhage, Renal failure, Shock
Clinical narrative: Gastrointestinal bleeding /  circulatory shock/ kidney failure leading to death
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Loss of personal independence in daily activities, Pain
Clinical narrative: Pain in the left arm at the injection site. More painful when moved certain directions (putting on clothes or taking clothes off). Pain doesn't get better with Aleve and pain has been there for 1 month now without going away.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Burning sensation, Paraesthesia, Urticaria
Clinical narrative: 24 HOURS AFTER VACCINATION OF BOTH SEQIRUS FLU AND PFIZER COVID-19 ON PATEINTS LEFT ARM PATIENT BROKE OUT IN HIVES AND FIREY TINGLING SENSATION THROUGHOUT BODY. PATIENTS SYMPTOMS PRESISTED SO PATIENT SOUGHT MEDICAL ATTENTION FROM A MEDICAL PROFESSIONAL. PATIENTS SYMPTOMS ARE PRESISITNG BUT TO A LESSER DEGREE.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asymptomatic COVID-19, Cerebral atrophy, Cerebral ischaemia, Confusional state
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of COPD, chronic resp failure, anxiety, and depression who presented to Hospital with acute delirium, UTI, and asymptomatic Covid19 positive on 12/11/22. She was S/P left hip fx and surgery at hospital on 11/24/22. She presented from SNF where she was receiving rehab after her hip surgery (otherwise, pt lives with her granddaughter).    Acute metabolic encephalopathy - resolved Acute, complicated UTI Presented w/confusion, UTI, and COVID Metabolic encephalopathy related to UTI and COVID infection MRI of brain showed cerebral volume loss with chronic microvascular ischemic changes. Received one day of Keflex, pt tolerated - was transitioned to IV ancef for 3 days - Will be discharged with Keflex for the rest of 10-day antibiotic course (6 remaining days)   Covid-19 Virus Infection - asymptomatic Acute on Chronic Hypoxic Respiratory Failure - resolved Date of onset of symptoms: asymptomatic Symptoms present on admission: asymptomatic but now requiring  Date of covid positive test: 12/11/22 Vaccination status: vaccinated Imaging: CXR (12/11) no acute cardiopulmonary abnormality, will order CTPA pending after fluids  Oxygen requirements on admission: 2-4  liters, 2L at baseline Received corticosteroids and remdesivir while inpatient.   COPD - w/o exacerbation Chronic respiratory failure - resolved Home oxygen of 2L, currently on baseline O2 supplementation Continue on discharge home regimen albuterol nebulized as needed Xopenex puffer as needed, and Trelegy Ellipta (formulary equivalent)   S/P left hip fracture and femur surgery (11/24) Adv to f/u 2 weeks post-op, pt unable to follow-up as presented to hospital on 12/11 Staples from hip surgery removed here in hospital on 12/14 Continue on discharge home vitamin D3, pain medications, PT/OT/SW c/s   Anxiety/depression Continue on discharge home Zoloft 150 mg daily and mirtazapine 7.5 mg at bedtime Continue on discharge melatonin as aided pt in obtaining restful sleep.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Delirium, Magnetic resonance imaging head abnormal, Metabolic encephalopathy, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of COPD, chronic resp failure, anxiety, and depression who presented to Hospital with acute delirium, UTI, and asymptomatic Covid19 positive on 12/11/22. She was S/P left hip fx and surgery at hospital on 11/24/22. She presented from SNF where she was receiving rehab after her hip surgery (otherwise, pt lives with her granddaughter).    Acute metabolic encephalopathy - resolved Acute, complicated UTI Presented w/confusion, UTI, and COVID Metabolic encephalopathy related to UTI and COVID infection MRI of brain showed cerebral volume loss with chronic microvascular ischemic changes. Received one day of Keflex, pt tolerated - was transitioned to IV ancef for 3 days - Will be discharged with Keflex for the rest of 10-day antibiotic course (6 remaining days)   Covid-19 Virus Infection - asymptomatic Acute on Chronic Hypoxic Respiratory Failure - resolved Date of onset of symptoms: asymptomatic Symptoms present on admission: asymptomatic but now requiring  Date of covid positive test: 12/11/22 Vaccination status: vaccinated Imaging: CXR (12/11) no acute cardiopulmonary abnormality, will order CTPA pending after fluids  Oxygen requirements on admission: 2-4  liters, 2L at baseline Received corticosteroids and remdesivir while inpatient.   COPD - w/o exacerbation Chronic respiratory failure - resolved Home oxygen of 2L, currently on baseline O2 supplementation Continue on discharge home regimen albuterol nebulized as needed Xopenex puffer as needed, and Trelegy Ellipta (formulary equivalent)   S/P left hip fracture and femur surgery (11/24) Adv to f/u 2 weeks post-op, pt unable to follow-up as presented to hospital on 12/11 Staples from hip surgery removed here in hospital on 12/14 Continue on discharge home vitamin D3, pain medications, PT/OT/SW c/s   Anxiety/depression Continue on discharge home Zoloft 150 mg daily and mirtazapine 7.5 mg at bedtime Continue on discharge melatonin as aided pt in obtaining restful sleep.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of COPD, chronic resp failure, anxiety, and depression who presented to Hospital with acute delirium, UTI, and asymptomatic Covid19 positive on 12/11/22. She was S/P left hip fx and surgery at hospital on 11/24/22. She presented from SNF where she was receiving rehab after her hip surgery (otherwise, pt lives with her granddaughter).    Acute metabolic encephalopathy - resolved Acute, complicated UTI Presented w/confusion, UTI, and COVID Metabolic encephalopathy related to UTI and COVID infection MRI of brain showed cerebral volume loss with chronic microvascular ischemic changes. Received one day of Keflex, pt tolerated - was transitioned to IV ancef for 3 days - Will be discharged with Keflex for the rest of 10-day antibiotic course (6 remaining days)   Covid-19 Virus Infection - asymptomatic Acute on Chronic Hypoxic Respiratory Failure - resolved Date of onset of symptoms: asymptomatic Symptoms present on admission: asymptomatic but now requiring  Date of covid positive test: 12/11/22 Vaccination status: vaccinated Imaging: CXR (12/11) no acute cardiopulmonary abnormality, will order CTPA pending after fluids  Oxygen requirements on admission: 2-4  liters, 2L at baseline Received corticosteroids and remdesivir while inpatient.   COPD - w/o exacerbation Chronic respiratory failure - resolved Home oxygen of 2L, currently on baseline O2 supplementation Continue on discharge home regimen albuterol nebulized as needed Xopenex puffer as needed, and Trelegy Ellipta (formulary equivalent)   S/P left hip fracture and femur surgery (11/24) Adv to f/u 2 weeks post-op, pt unable to follow-up as presented to hospital on 12/11 Staples from hip surgery removed here in hospital on 12/14 Continue on discharge home vitamin D3, pain medications, PT/OT/SW c/s   Anxiety/depression Continue on discharge home Zoloft 150 mg daily and mirtazapine 7.5 mg at bedtime Continue on discharge melatonin as aided pt in obtaining restful sleep.